Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid

作者: François Lamoureux , Benjamin Ory , Séverine Battaglia , Paul Pilet , Marie-Françoise Heymann

DOI: 10.1002/IJC.23187

关键词:

摘要: Animal models that mimic osteoblastic metastases associated with prostate carcinoma are required to improve the therapeutic options in humans. A new model was then developed and characterized immunocompetent rats. The bisphosphonate zoledronic acid (ZOL) tested validate this as a application. Rat AT6-1 tumor cells were vitro at transcriptional (bone epithelial markers) functional (induction of mineralized nodules) levels. bone lesions induced after their direct injection into femur marrow by radiography, microscanner histology analyses. ZOL effects studied vivo on lesion development cell proliferation, apoptosis cycle analysis. Apart from markers, express an osteoblast phenotype they markers able induce nodule formation vitro. disorganization trabecular growth zone level observed intraosseous well cortical erosion. itself is revealed SEM analysis polarized light microscopy. prevents such lesions, related inhibitory effect proliferation independent caspase 3 activation, but arrest. rat validated rats used show relevance using compound shows bifunctional both remodelling proliferation.

参考文章(44)
Jun Shimazaki, Tsutou Higa, Susumu Akimoto, Motoyuki Masai, Shigeo Isaka, Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray. Advances in Experimental Medicine and Biology. ,vol. 324, pp. 269- 275 ,(1992) , 10.1007/978-1-4615-3398-6_29
Koutsilieris M, PA-III rat prostate adenocarcinoma cells (review). in Vivo. ,vol. 6, pp. 199- 203 ,(1992)
Margaret V. Lee, Frederick R. Singer, R. Sean Guenette, Eva M. Fong, Bisphosphonate Treatment Inhibits the Growth of Prostate Cancer Cells Cancer Research. ,vol. 61, pp. 2602- 2608 ,(2001)
Robert L. Vessella, Martine P. Roudier, Lisha G. Brown, Janna E. Quinn, Eva Corey, Martin Poot, Celestia S. Higano, Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer Clinical Cancer Research. ,vol. 9, pp. 295- 306 ,(2003)
Shahrokh F Shariat, Moshe Shalev, Andres Menesses-Diaz, Isaac Yi Kim, Michael W Kattan, Thomas M Wheeler, Kevin M Slawin, None, Preoperative Plasma Levels of Transforming Growth Factor Beta1(TGF-β1) Strongly Predict Progression in Patients Undergoing Radical Prostatectomy Journal of Clinical Oncology. ,vol. 19, pp. 2856- 2864 ,(2001) , 10.1200/JCO.2001.19.11.2856
Claire M Shipman, Peter I Croucher, R Graham, G Russell, Miep H Helfrich, Michael J Rogers, None, The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway Cancer Research. ,vol. 58, pp. 5294- 5297 ,(1998)
Toshiyuki Yoneda, Cellular and molecular basis of preferential metastasis of breast cancer to bone. Journal of Orthopaedic Science. ,vol. 5, pp. 75- 81 ,(2000) , 10.1007/S007760050012
Y Ke, C Beesley, P Smith, R Barraclough, P Rudland, CS Foster, Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells. British Journal of Cancer. ,vol. 77, pp. 287- 296 ,(1998) , 10.1038/BJC.1998.45
Lukas Bubendorf, Alain Schöpfer, Urs Wagner, Guido Sauter, Holger Moch, Niels Willi, Thomas C. Gasser, Michael J. Mihatsch, Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Human Pathology. ,vol. 31, pp. 578- 583 ,(2000) , 10.1053/HP.2000.6698